en
The present invention relates to the use of a rosemary extract in the preparation of a composition for treating a cancer, in which there is a change in oestrogen signalling or lipid metabolism, to a composition comprising rosemary extract and a chemotherapeutic agent, and also to an in-vitro method for predicting the clinical response to an anti-tumour therapy using said composition.
Datos clave
CategoríaInvención
Índice de la ficha
- Updated at
- 05/11/2026
- Numero publicacion
- WO.2013060922.A1
- Fecha publicacion
- 02/05/2013
- Anio publicacion
- 2013
- Numero solicitud
- WO2012ES70750
- Fecha presentacion
- 26/10/2012
Etiquetas
Inventores
Ramirez de Molina, AnaRamirez de Molina AnaMolina Arranz SusanaMolina Arranz, SusanaGonzalez-Vallinas Garrachon, MargaritaGonzalez-Vallinas Garrachon MargaritaRodriguez Garcia-Risco, MonicaRodriguez Garcia-Risco MonicaReglero Rada, Guillermo J.Reglero Rada Guillermo JFornari Reale, TizianaFornari Reale Tiziana
Solicitantes
Universidad Autónoma de MadridFundación IMDEA Alimentación
Clasificacion ipc
A61K 36/ 53 A IA61P 35/ 00 A I